Search tips
Search criteria 


Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. 1995 November; 103(Suppl 8): 275–281.
PMCID: PMC1518956
Research Article

Differences in cancer incidence, mortality, and survival between African Americans and whites.


This report highlights selected evidence of different cancer patterns among African Americans and whites and considers potential risk factors associated with these cancers. During the years 1987 to 1991, African Americans experienced higher incidence and mortality rates than whites for multiple myeloma and for cancers of the oropharynx, colorectum, lung and bronchus, cervix, and prostate. African Americans had lower incidence and mortality for cancer of the urinary bladder. The incidence of breast cancer was higher among white women, but mortality was higher among African American women. Five-year relative survival for the period 1983 to 1990 was generally lower among African Americans than whites for cancers of the oropharynx, colorectum, cervix, prostate, and female breast but slightly higher for multiple myeloma. From 1973 to 1991, there were significant declines in cervical cancer incidence among women of both races, oropharyngeal cancer mortality among whites, and bladder cancer mortality for whites and African Americans. Risk factors for the more prominent cancers suggest that efforts aimed at changing lifestyles, achieving socioeconomic parity, and insuring environmental equity are likely to relieve African Americans of much of their disproportionate cancer burden.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Terris M. Desegregating health statistics. Am J Public Health. 1973 Jun;63(6):477–480. [PubMed]
  • Feldman JJ, Makuc DM, Kleinman JC, Cornoni-Huntley J. National trends in educational differentials in mortality. Am J Epidemiol. 1989 May;129(5):919–933. [PubMed]
  • Marmot MG, Kogevinas M, Elston MA. Social/economic status and disease. Annu Rev Public Health. 1987;8:111–135. [PubMed]
  • Sorlie P, Rogot E, Anderson R, Johnson NJ, Backlund E. Black-white mortality differences by family income. Lancet. 1992 Aug 8;340(8815):346–350. [PubMed]
  • Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, Schoenberg JB, Winn DM, McLaughlin JK, Fraumeni JF., Jr Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst. 1993 Mar 17;85(6):465–473. [PubMed]
  • Steele GD., Jr The National Cancer Data Base report on colorectal cancer. Cancer. 1994 Oct 1;74(7):1979–1989. [PubMed]
  • Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15(2):499–545. [PubMed]
  • Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993 Jun 15;71(12):3827–3838. [PubMed]
  • Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A, Harris CC. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):515–518. [PubMed]
  • Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF, Harris CC. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis. 1994 Apr;15(4):583–587. [PubMed]
  • Shields PG, Caporaso NE, Falk RT, Sugimura H, Trivers GE, Trump BF, Hoover RN, Weston A, Harris CC. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):481–485. [PubMed]
  • Weston A, Perrin LS, Forrester K, Hoover RN, Trump BF, Harris CC, Caporaso NE. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):481–483. [PubMed]
  • McWhorter WP, Schatzkin AG, Horm JW, Brown CC. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer. 1989 Mar 1;63(5):982–987. [PubMed]
  • Lloyd JW. Long-term mortality study of steelworkers. V. Respiratory cancer in coke plant workers. J Occup Med. 1971 Feb;13(2):53–68. [PubMed]
  • Swanson GM, Satariano ER, Satariano WA, Threatt BA. Racial differences in the early detection of breast cancer in metropolitan Detroit, 1978 to 1987. Cancer. 1990 Sep 15;66(6):1297–1301. [PubMed]
  • Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993 Jul 8;329(2):103–109. [PubMed]
  • Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47. [PubMed]
  • Krieger N. Social class and the black/white crossover in the age-specific incidence of breast cancer: a study linking census-derived data to population-based registry records. Am J Epidemiol. 1990 May;131(5):804–814. [PubMed]
  • Swanson GM, Ragheb NE, Lin CS, Hankey BF, Miller B, Horn-Ross P, White E, Liff JM, Harlan LC, McWhorter WP, et al. Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease. Cancer. 1993 Aug 1;72(3):788–798. [PubMed]
  • Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994 Sep 28;272(12):947–954. [PubMed]
  • Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35. [PubMed]
  • Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer. 1994 Aug 1;74(3 Suppl):1111–1124. [PubMed]
  • Barrett-Connor E. Postmenopausal estrogen and the risk of breast cancer. Ann Epidemiol. 1994 May;4(3):177–180. [PubMed]
  • White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst. 1994 Apr 6;86(7):505–514. [PubMed]
  • Schatzkin A, Longnecker MP. Alcohol and breast cancer. Where are we now and where do we go from here? Cancer. 1994 Aug 1;74(3 Suppl):1101–1110. [PubMed]
  • Field NA, Baptiste MS, Nasca PC, Metzger BB. Cigarette smoking and breast cancer. Int J Epidemiol. 1992 Oct;21(5):842–848. [PubMed]
  • Bergner L. Race, health, and health services. Am J Public Health. 1993 Jul;83(7):939–941. [PubMed]
  • Brown ML, Kessler LG, Rueter FG. Is the supply of mammography machines outstripping need and demand? An economic analysis. Ann Intern Med. 1990 Oct 1;113(7):547–552. [PubMed]
  • Caplan LS, Wells BL, Haynes S. Breast cancer screening among older racial/ethnic minorities and whites: barriers to early detection. J Gerontol. 1992 Nov;47(Spec No):101–110. [PubMed]
  • Mayberry RM. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol. 1994 May;4(3):205–213. [PubMed]
  • Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst. 1994 Apr 20;86(8):589–599. [PubMed]
  • Howe GR. Dietary fat and breast cancer risks. An epidemiologic perspective. Cancer. 1994 Aug 1;74(3 Suppl):1078–1084. [PubMed]
  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. [PubMed]
  • Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994 Oct 7;266(5182):120–122. [PubMed]
  • Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993 Jul 21;85(14):1129–1137. [PubMed]
  • Lacey L. Cancer prevention and early detection strategies for reaching underserved urban, low-income black women. Barriers and objectives. Cancer. 1993 Aug 1;72(3 Suppl):1078–1083. [PubMed]
  • Walker AR, Walker BF, Segal I. Cancer patterns in three African populations compared with the United States black population. Eur J Cancer Prev. 1993 Jul;2(4):313–320. [PubMed]
  • Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev. 1991;13:200–227. [PubMed]
  • Mettlin CJ, Murphy G. The National Cancer Data Base report on prostate cancer. Cancer. 1994 Sep 1;74(5):1640–1648. [PubMed]
  • Brawn PN, Johnson EH, Speights VO, Riggs M, Kuhl D, Abel PD, Lind M, Bell N. Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms. Cancer. 1994 Sep 1;74(5):1607–1611. [PubMed]
  • Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening. Cancer. 1991 Mar 1;67(5):1454–1459. [PubMed]
  • Dosemeci M, Hoover RN, Blair A, Figgs LW, Devesa S, Grauman D, Fraumeni JF., Jr Farming and prostate cancer among African-Americans in the southeastern United States. J Natl Cancer Inst. 1994 Nov 16;86(22):1718–1719. [PubMed]
  • Hayes RB, Pottern LM, Greenberg R, Schoenberg J, Swanson GM, Liff J, Schwartz AG, Brown LM, Hoover RN. Vasectomy and prostate cancer in US blacks and whites. Am J Epidemiol. 1993 Feb 1;137(3):263–269. [PubMed]
  • Hayes RB, Pottern LM, Swanson GM, Liff JM, Schoenberg JB, Greenberg RS, Schwartz AG, Brown LM, Silverman DT, Hoover RN. Tobacco use and prostate cancer in blacks and whites in the United States. Cancer Causes Control. 1994 May;5(3):221–226. [PubMed]
  • Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17(4):337–347. [PubMed]
  • Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol. 1991 Nov;146(5):1305–1307. [PubMed]
  • Schuman LM, Mandel J, Blackard C, Bauer H, Scarlett J, McHugh R. Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep. 1977 Mar-Apr;61(2):181–186. [PubMed]
  • Satariano WA, Swanson GM. Racial differences in cancer incidence: the significance of age-specific patterns. Cancer. 1988 Dec 15;62(12):2640–2653. [PubMed]
  • Schairer C, Hartge P, Hoover RN, Silverman DT. Racial differences in bladder cancer risk: a case-control study. Am J Epidemiol. 1988 Nov;128(5):1027–1037. [PubMed]
  • Riedel DA, Pottern LM. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am. 1992 Apr;6(2):225–247. [PubMed]
  • Figgs LW, Dosemeci M, Blair A. Risk of multiple myeloma by occupation and industry among men and women: a 24-state death certificate study. J Occup Med. 1994 Nov;36(11):1210–1221. [PubMed]
  • Pottern LM, Gart JJ, Nam JM, Dunston G, Wilson J, Greenberg R, Schoenberg J, Swanson GM, Liff J, Schwartz AG, et al. HLA and multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiol Biomarkers Prev. 1992 Mar-Apr;1(3):177–182. [PubMed]
  • Lewis DR, Pottern LM, Brown LM, Silverman DT, Hayes RB, Schoenberg JB, Greenberg RS, Swanson GM, Schwartz AG, Liff JM, et al. Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control. 1994 Nov;5(6):529–539. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science